SCHEMBL7562044

SCHEMBL7562044

CC(=NNc1cccc(C#N)c1)OS(=O)(=O)c1ccc(C)cc1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.43
POLB P06746 1/20 0.43
KCNJ6 P48051 1/20 0.37
KCNJ5 P48544 1/20 0.37
KCNJ3 P48549 1/20 0.37
PDK1 Q15118 1/20 0.37
PDK2 Q15119 1/20 0.37
PDK3 Q15120 1/20 0.37
PDK4 Q16654 1/20 0.37
P2RY2 P41231 1/20 0.37
GPR17 Q13304 1/20 0.37
SLC22A12 Q96S37 1/20 0.36
IDO1 P14902 1/20 0.35
TBXA2R P21731 2/20 0.35
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
KMT2A Q03164 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7474554 0.84 P2RY2 (0.44) SMN1; SMN2POLBKCNJ6KCNJ5KCNJ3
SCHEMBL7568797 0.73 P2RY2 (0.42) SMN1; SMN2POLBKCNJ6KCNJ5KCNJ3
SCHEMBL7637263 0.73 P2RY2 (0.42) SMN1; SMN2POLBKCNJ6KCNJ5KCNJ3
SCHEMBL7568763 0.69 PDK1 (0.45) SMN1; SMN2POLBKCNJ6KCNJ5KCNJ3
SCHEMBL7571560 0.69 PDK1 (0.45) SMN1; SMN2POLBKCNJ6KCNJ5KCNJ3
SCHEMBL25888267 0.66 PDK1 (0.49) SMN1; SMN2POLBPDK1PDK2PDK3
SCHEMBL23928549 0.65 MAPT (0.49) SMN1; SMN2MEN1ALDH1A1MAPTKMT2A
SCHEMBL16324250 0.63 PDCD1 (0.50) SMN1; SMN2MEN1ALDH1A1MAPTKMT2A
SCHEMBL16361796 0.63 PDCD1 (0.50) SMN1; SMN2MEN1ALDH1A1MAPTKMT2A
SCHEMBL16324249 0.63 PDCD1 (0.50) SMN1; SMN2MEN1ALDH1A1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1222172-A1 SYNTHESIS OF 1,3,5-TRISUBSTITUTED PYRAZOLES AND INTERMEDIATES THEREFORE Bristol-Myers Squibb Pharma Company (US) 2002-07-17 EP disclosed
WO-2001029006-A1 SYNTHESIS OF 1,3,5-TRISUBSTITUTED PYRAZOLES AND INTERMEDIATES THEREFORE BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-04-26 WO disclosed